Higher hypothetical disease risk linked with greater willingness to vaccinate

October 15, 2020

A survey of U.S. adults showed that as local case counts of a hypothetical disease increased--indicating increased risk of infection--the proportion of people willing to receive a vaccine for the disease also increased. Bert Baumgaertner of the University of Idaho, Moscow, United States and colleagues present these findings in the open-access journal PLOS Medicine.

People may be hesitant to receive a vaccine for several reasons, such as lack of confidence in the vaccine, lack of convenient access to the vaccine, or low perceived risk of contracting the disease. A better understanding of these reasons could aid efforts to mitigate disease spread. However, links between vaccine hesitancy and perceived risk of disease have been unclear.

Now, Baumgaertner and colleagues investigate the concept of vaccine propensity: how willing a person is to vaccinate according to their perceived risk of infection, assuming vaccine confidence and convenience remain unchanged. In 2018, the researchers explored vaccine propensity with an online survey that presented hypothetical disease scenarios to about 2,500 U.S. adults and asked how high their local community's case count would need to be before they would be willing to vaccinate.

The survey results showed that a greater number of local cases (indicating greater risk) was associated with an increase in the proportion of the individuals willing to vaccinate, increasing from approximately 50% to 90% as local case numbers went from zero to 100. Participants randomly received different disease scenarios, and vaccination willingness was greater for participants who were given information about the potential deadliness of a disease, versus those told how severely it could impact daily life.

Older participants, those with high incomes, and men were generally more willing to vaccinate. Participants who leaned farther towards a conservative political ideology showed less willingness to vaccinate than those who reported being liberal. Moderates tended to align with conservatives' willingness at lower risk levels, but as risk increased, the proportion of moderates willing to vaccinate aligned more closely with that of liberal participants. The authors note that although education level of participants generally matched that of the general population, the survey was designed to be representative of the U.S. population in terms of age, sex, income, race/ethnicity, and geographic region, and does not include individuals who do not have internet access.

These insights into how perceived risk associates with people's willingness to vaccinate could aid efforts to boost vaccination. Advances in understanding willingness to vaccinate could also help improve predictive models of disease spread that incorporate feedback on people's vaccination decisions.
Research Article

Peer reviewed; Observational study; Humans

In your coverage please use this URL to provide access to the freely available paper: http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003354

Funding: Research reported in this publication was supported by the National Institute Of General Medical Sciences of the National Institutes of Health under Award Number P20GM104420 (BB, BJR, CRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests exist.

Citation: Baumgaertner B, Ridenhour BJ, Justwan F, Carlisle JE, Miller CR (2020) Risk of disease and willingness to vaccinate in the United States: A population-based survey. PLoS Med 17(10): e1003354. https://doi.org/10.1371/journal.pmed.1003354


Related Vaccine Articles from Brightsurf:

Who should get the COVID-19 vaccine first?
Nineteen global health experts from around the world have proposed a new, three-phase plan for vaccine distribution -- called the Fair Priority Model -- which aims to reduce premature deaths and other irreversible health consequences from COVID-19.

Breakthrough with cancer vaccine
Scientists have developed a new cancer vaccine with the potential to activate the body's immune system to fight a range of cancers, including leukaemia, breast cancer, lung cancer and pancreatic cancers.

How to improve the pneumococcus vaccine
Pneumococcus kills 1 million children annually according to the World Health Organization.

US inroads to better Ebola vaccine
As the world focuses on finding a COVID-19 vaccine, research continues on other potentially catastrophic pandemic diseases, including Ebola and Marburg viruses.

Successful MERS vaccine in mice may hold promise for COVID-19 vaccine
In a new study, published April 7 in mBio, researchers from the University of Iowa and the University of Georgia demonstrate that a new vaccine fully protects mice against a lethal dose of MERS, a close cousin of COVID-19.

Coronavirus Vaccine: Where are we and what's next? (video)
You might have heard that COVID-19 vaccine trials are underway in Seattle.

Why isn't there a vaccine for staph?
A study from Washington University School of Medicine in St.

Exposing vaccine hesitant to real-life pain of diseases makes them more pro-vaccine
New research from Brigham Young University professors finds there is a better way to help increase support for vaccinations: Expose people to the pain and suffering caused by vaccine-preventable diseases instead of trying to combat people with vaccine facts.

Lifetime flu vaccine?
Another year, another flu vaccine because so far scientists haven't managed to make a vaccine that protects against all strains of flu.

On the horizon: An acne vaccine
A new study published in the Journal of Investigative Dermatology reports important steps that have been taken towards the development of an acne vaccine.

Read More: Vaccine News and Vaccine Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.